CRL - Company ID 0001100682
The table below shows CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $191.83M | $207.10M | $182.82M | $229.36M | $210.17M | $179.21M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $700.25M | $734.48M | $767.57M | $756.63M | $754.21M | $762.22M |
| Inventory | $359.72M | $302.55M | $279.55M | $290.16M | $336.20M | $349.11M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.49B |
| $1.53B |
| $1.47B |
| $1.51B |
| $1.49B |
| $1.50B |
| Property, plant & equipment | $1.51B | $1.59B | $1.61B | $1.59B | - | - |
| Goodwill | $3.04B | $2.92B | $2.94B | $2.87B | $3.12B | $3.08B |
| Total assets | $7.73B | $7.51B | $7.56B | $7.58B | $8.00B | $7.95B |
| Accounts payable | $133.95M | $169.62M | $145.80M | $149.33M | $135.96M | $133.10M |
| Total current liabilities | $1.09B | $1.12B | $1.08B | $1.05B | $1.01B | $947.52M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $4.74B | $4.06B | $4.16B | $4.34B | $4.18B | $4.18B |
| Retained earnings | $1.37B | $1.94B | $1.89B | $1.84B | $2.12B | $2.05B |
| Total equity | $2.94B | $3.41B | $3.35B | $3.19B | $3.78B | $3.72B |